MetLife Investment Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$132,196
-34.4%
30,6010.0%0.00%
-50.0%
Q2 2023$201,661
-2.9%
30,6010.0%0.00%0.0%
Q1 2023$207,780
-8.1%
30,6010.0%0.00%0.0%
Q4 2022$226,141
-25.2%
30,6010.0%0.00%
-33.3%
Q3 2022$302,338
-9.4%
30,6010.0%0.00%0.0%
Q2 2022$333,551
-3.6%
30,6010.0%0.00%
+50.0%
Q1 2022$346,097
+12.5%
30,601
+56.0%
0.00%
-33.3%
Q4 2021$307,712
+9.9%
19,612
+20.1%
0.00%0.0%
Q3 2021$279,913
-39.1%
16,331
-23.6%
0.00%
-25.0%
Q2 2021$459,970
+43.2%
21,3840.0%0.00%
+33.3%
Q1 2021$321,188
+0.4%
21,384
-12.1%
0.00%0.0%
Q4 2020$319,775
+36.0%
24,3360.0%0.00%0.0%
Q3 2020$235,086
-15.6%
24,3360.0%0.00%0.0%
Q2 2020$278,404
+10.4%
24,3360.0%0.00%
-25.0%
Q1 2020$252,121
-36.9%
24,3360.0%0.00%0.0%
Q4 2019$399,354
+23.6%
24,3360.0%0.00%0.0%
Q3 2019$323,182
-5.7%
24,3360.0%0.00%0.0%
Q2 2019$342,894
-23.4%
24,3360.0%0.00%
-20.0%
Q1 2019$447,782
-29.6%
24,3360.0%0.01%
-37.5%
Q4 2018$635,900
+13.9%
24,3360.0%0.01%
+33.3%
Q3 2018$558,511
+20.4%
24,3360.0%0.01%
+20.0%
Q2 2018$464,000
+35.7%
24,336
+20.0%
0.01%
+25.0%
Q1 2018$342,000
+11.0%
20,2730.0%0.00%
+33.3%
Q4 2017$308,00020,2730.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders